SG170804A1 - Pseudomonas aeruginosa outer membrane protein pa0427 - Google Patents

Pseudomonas aeruginosa outer membrane protein pa0427

Info

Publication number
SG170804A1
SG170804A1 SG201102257-1A SG2011022571A SG170804A1 SG 170804 A1 SG170804 A1 SG 170804A1 SG 2011022571 A SG2011022571 A SG 2011022571A SG 170804 A1 SG170804 A1 SG 170804A1
Authority
SG
Singapore
Prior art keywords
pseudomonas aeruginosa
outer membrane
membrane protein
aeruginosa outer
protein
Prior art date
Application number
SG201102257-1A
Other languages
English (en)
Inventor
Jiro Tanaka
Fukuichi Ohsawa
Takafumi Okutomi
Hiroshi Nagaso
Masashi Kumagai
Takahisa Suzuki
Keiko Otsuka
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of SG170804A1 publication Critical patent/SG170804A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG201102257-1A 2006-03-30 2007-03-30 Pseudomonas aeruginosa outer membrane protein pa0427 SG170804A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006095996 2006-03-30

Publications (1)

Publication Number Publication Date
SG170804A1 true SG170804A1 (en) 2011-05-30

Family

ID=38563607

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201102257-1A SG170804A1 (en) 2006-03-30 2007-03-30 Pseudomonas aeruginosa outer membrane protein pa0427

Country Status (9)

Country Link
US (1) US8084044B2 (fr)
EP (1) EP2011867A4 (fr)
JP (1) JPWO2007114340A1 (fr)
KR (1) KR20080113239A (fr)
CN (1) CN101454446A (fr)
AU (1) AU2007232894B2 (fr)
CA (1) CA2645904A1 (fr)
SG (1) SG170804A1 (fr)
WO (1) WO2007114340A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090155279A1 (en) * 2005-10-28 2009-06-18 Jiro Tanaka Pseudomonas Aeruginosa Outer Membrane Protein PA5158
AU2008342152B2 (en) * 2007-12-25 2013-06-27 Meiji Seika Pharma Co., Ltd. Component protein PA1698 for type-III secretion system of Pseudomonas aeruginosa
EA020544B1 (ru) * 2008-01-10 2014-12-30 Шионоги Энд Ко., Лтд. АНТИТЕЛА ПРОТИВ PcrV
CN102341496B (zh) 2009-03-11 2014-07-02 盐野义制药株式会社 具有抗绿脓杆菌作用的人源化PcrV抗体
CA2855894A1 (fr) * 2011-12-20 2013-06-27 Merck Sharp & Dohme Corp. Epitopes oprm de pseudomonas aeruginosa pour une utilisation dans le diagnostic et la therapie
US20180201656A1 (en) * 2015-07-04 2018-07-19 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
CN105424929B (zh) * 2015-11-24 2017-08-08 四川夹金山逢春养殖科技有限公司 一种铜绿假单胞菌抗体检测试剂盒及检测方法
CN105669844B (zh) * 2016-03-02 2019-11-08 中国人民解放军第三军医大学 一种铜绿假单胞菌重组蛋白Vac33的纯化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE3463211D1 (en) 1983-07-01 1987-05-21 Battelle Memorial Institute Biodegradable polypeptide and its use in the sustained release of medicaments
US5417986A (en) 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP1690934A3 (fr) 1990-01-12 2008-07-30 Abgenix, Inc. Génération d'anticorps xenogéniques
CA2089661C (fr) 1990-08-29 2007-04-03 Nils Lonberg Animaux transgeniques non humains capables de produire des anticorps heterologues
JPH11206387A (ja) 1991-08-28 1999-08-03 Genpharm Internatl Inc 異種免疫グロブリンを作る方法及びそのためのトランスジェニックマウス
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CU22615A1 (es) 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
ATE190657T1 (de) 1994-12-16 2000-04-15 Chiron Behring Gmbh & Co Immunogenes hybridprotein oprf-oprl erhältlich aus membranproteinen von pseudomonas aeruginosa
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
ES2379801T3 (es) 1998-11-25 2012-05-03 Mcw Research Foundation, Incorporated Método para diagnosticar una infección por pseudomonas aeruginosa
US20030228324A1 (en) 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
US20090155279A1 (en) * 2005-10-28 2009-06-18 Jiro Tanaka Pseudomonas Aeruginosa Outer Membrane Protein PA5158

Also Published As

Publication number Publication date
CA2645904A1 (fr) 2007-10-11
AU2007232894A1 (en) 2007-10-11
EP2011867A4 (fr) 2009-11-25
AU2007232894B2 (en) 2013-01-31
CN101454446A (zh) 2009-06-10
US20090117121A1 (en) 2009-05-07
WO2007114340A1 (fr) 2007-10-11
JPWO2007114340A1 (ja) 2009-08-20
EP2011867A1 (fr) 2009-01-07
KR20080113239A (ko) 2008-12-29
US8084044B2 (en) 2011-12-27

Similar Documents

Publication Publication Date Title
SG170804A1 (en) Pseudomonas aeruginosa outer membrane protein pa0427
NL301089I2 (nl) imlifidase
ECSP099833A (es) Anticuerpos humanizados contra el globulomero a?(20-42) y sus usos
WO2007056457A3 (fr) Procedes, compositions et kits pour le traitement de pathologies
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
CR10730A (es) Anticuerpos agonistas anti notch3 y su uso en el tratamiento de las enfermedades relacionadas con el gen notch3
WO2008070344A3 (fr) Compositions et procédés permettant une liaison sphingosine-1-phosphate
MY181969A (en) Anti-n3pglu amyloid beta peptide antibodies and uses thereof
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
UA94221C2 (en) Lipocalin protein
WO2012021786A3 (fr) Compositions d'anticorps anti-hemagglutinine et ses méthodes d'utilisation
GEP20115195B (en) Antibodies directed against amyloid-beta peptide and use thereof
TW201129378A (en) Materials and methods for treating or preventing HER-3 associated diseases
MX2010006096A (es) Anticuerpo anti-nr10 y su uso.
MY149630A (en) Antibodies against amyloid-beta peptide
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
WO2006086799A3 (fr) Reactifs de peptide specifiques au prion
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
MX2010005871A (es) Anticuerpos al antigeno de pcrv de pseudomonas aeruginosa.
WO2008071418A3 (fr) Traitement
JO3358B1 (ar) معالجات حساسية العيون
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
WO2007111661A3 (fr) anticorps humains specifiques a des matieres et des procedes a base de gastrine
SI2109623T1 (sl) Zdravljenje raka z anti il protitelesi